Cytosorbents (CTSO) Change in Inventory (2011 - 2026)
Cytosorbents' (CTSO) quarterly Change in Inventory came in at -$723000.0 in Q1 2026, down 463.32% YoY from $199000.0 in Q1 2025, and down 155.92% on a QoQ basis from $1.3 million in Q4 2025.
Cytosorbents (CTSO) Change in Inventory (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Change in Inventory data on file, last reported at -$723000.0 in Q1 2026.
- Quarterly Change in Inventory fell 463.32% year-over-year to -$723000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 321.38% YoY) and the FY2025 annual result came in at $2.5 million, up 608.0% from the prior year.
- Change in Inventory fell to -$723000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.3 million in Q4 2025 to a low of -$1.7 million in Q1 2023.
- A 5-year average of $11080.9 and a median of $288549.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2025 — Change in Inventory soared 472.62% — and 2026, when it plunged 463.32%.
- Tracing CTSO's Change in Inventory over 5 years: stood at -$485918.0 in 2022, then surged by 159.38% to $288549.0 in 2023, then sank by 220.26% to -$347000.0 in 2024, then soared by 472.62% to $1.3 million in 2025, then plunged by 155.92% to -$723000.0 in 2026.
- The last three Change in Inventory figures came in at -$723000.0 (Q1 2026), $1.3 million (Q4 2025), and $322000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 301.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 113.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 133.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 23.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 36.40 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 139.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -131.35 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 73.30 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -789,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -789,000.00 |
| Jun 30, 2026 | -789,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 322,000.00 |
| Sep 30, 2025 | 322,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | -347,000.00 |
| Dec 31, 2024 | -347,000.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | 600,131.00 |
| Jun 30, 2024 | 600,131.00 |
| Mar 31, 2024 | 429,869.00 |
| Mar 31, 2024 | 429,869.00 |